Ginkgo Bioworks falls short on Q4 revenue and projects weak 2025 guidance. Learn about DNA stock's valuation risks, cash ...

There’s plenty of empty lab space around Greater Boston these days, and a lot of competition for life-science tenants. Now ...

Ginkgo Bioworks' restructuring has resulted in a dramatic reduction in cash burn in recent quarters. Read why I think DNA ...

Ginkgo already canceled its plans to move into Biofab1, a new 260,000-square-foot lab data center it's been building near its ...

Cell Engineering revenue $110M-$130M with potential upside from the recent launch of Tools offerings Ginkgo expects Biosecurity ...

Pre-earnings options volume in Ginkgo Bioworks (DNA) is normal with calls leading puts 8:5. Implied volatility suggests the market is ...

A police chief has torn up a diversity guide that told officers to avoid saying 'blacklisted' and 'black sheep' in case it offended anyone. Hertfordshire's Police and Crime Commissioner ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

We’re continuing to evaluate the potential risk posed by Ginkgo biloba extract before we publish our final conclusion. This includes: tracking new information on exposures or hazards asking the public ...

We have seen $122,757,178 of award payments to $DNA over the last year. $DNA insiders have traded $DNA stock on the open market 12 times in the past 6 months. Of ...

The leaf type of a plant determines its photosynthetic efficiency and adaptation to the environment. The normal leaves of modern Ginkgo biloba, which is known as a “living fossil” in gymnosperm, ...